Clinical Efficacy and Safety of “Vasavaleha” in the Management of Stable Chronic Bronchitis: A Prospective Open Label Multicenter Study

Journal of Research in Ayurvedic Sciences
doi 10.5005/jp-journals-10064-0023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Jaypee Brothers Medical Publishing

Related search

Efficacy and Safety of Moxifloxacin in Acute Exacerbations of Chronic Bronchitis: A Prospective, Multicenter, Observational Study (AVANTI)

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2013English

Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)

Journal of the Peripheral Nervous System
MedicineNeuroscienceNeurology
2013English

A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Current Oncology
Oncology
2011English

Efficacy and Safety of Octanorm (Cutaquig®) in Adults With Primary Immunodeficiencies With Predominant Antibody Deficiency: A Prospective, Open-Label Study

Immunotherapy
OncologyAllergyImmunology
2020English

An Open Label, Multicenter, Non-Comparative Study of the Efficacy and Safety of Oral Gatifloxacin in the Treatment of Community-Acquired Pneumonia: A Brazilian Study in Five Centers

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2003English

A Multicenter, Open Label, Uncontrolled, Phase Ii Trial Evaluating Safety and Efficacy of Venetoclax, Atezolizumab Andobinutuzumab in Richter Transformation From CLL

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Efficacy and Tolerability of Carbamazepine for the Treatment of Painful Diabetic Neuropathy in Adults: A 12-Week, Open-Label, Multicenter Study

International Journal of General Medicine
Medicine
2014English

The Maraviroc Expanded Access Program — Safety and Efficacy Data From an Open-Label Study

HIV Clinical Trials
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy